Pella v. Adams

702 F. Supp. 244, 1988 U.S. Dist. LEXIS 15110, 1988 WL 138217
CourtDistrict Court, D. Nevada
DecidedDecember 22, 1988
DocketCV-R-85-98-ECR
StatusPublished
Cited by7 cases

This text of 702 F. Supp. 244 (Pella v. Adams) is published on Counsel Stack Legal Research, covering District Court, D. Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pella v. Adams, 702 F. Supp. 244, 1988 U.S. Dist. LEXIS 15110, 1988 WL 138217 (D. Nev. 1988).

Opinion

ORDER

EDWARD C. REED, Jr., Chief Judge.

STATEMENT OF THE CASE

The matter before the Court is a civil rights action filed under 42 U.S.C. § 1983 by plaintiff Pella, an inmate at Northern Nevada Correctional Center (“NNCC”). Pella alleges that the three-member disciplinary committee at NNCC violated his constitutional due process rights when they found him guilty of ingesting marijuana. He argues that the defendants, the members of the disciplinary committee, did not have sufficient evidence to find him guilty because the urinalysis test relied on by them was scientifically flawed. In addition, Pella argues that the defendants violated his due process rights by refusing to allow him to obtain, at his own expense, an alternative urine test.

*245 The factual background of this case was set forth thoroughly in this Court’s previous order denying the defendants’ motion for summary judgment. 1 See Pella v. Adams, 638 F.Supp. 94, 95-96 (D.Nev. 1986). In brief, Pella’s disciplinary hearing arose from a routine search of his cell in which a correctional officer discovered several small seeds and a green leafy substance. On the basis of these findings, Pella was required to produce a urine sample. This urine sample was transported to the Washoe County Sheriff’s Criminalistic Laboratory and analyzed through the Enzyme Multiple Immunoassay Test (“EMIT” test). This test yielded a positive result, indicating the presence in Pella’s urine of Delta-9-tetrohydrocannabinol (THC), the principal psychoactive ingredient of marijuana and hashish. The Crime Lab then repeated the EMIT test and confirmed that Pella’s urine tested positively.

The evidence presented to the disciplinary committee consisted of the positive urinalysis test results and a written report describing the seeds and green leafy substance found in Pella’s cell. The seeds and the leafy substance were not chemically analyzed and no evidence as to their chemical composition was reported to the disciplinary committee. At his disciplinary hearing, Pella proclaimed his innocence and requested that his urine sample be retested, at his own expense, through a scientific method other than the EMIT test. The disciplinary committee denied this request without articulating a reason for the denial.

Based on the EMIT test results and the written description of Pella’s cell, the disciplinary committee found Pella guilty of ingesting marijuana, a major violation of the Code of Penal Discipline. 2 The committee sentenced him to fifteen days of disciplinary detention and referred the case to the Nevada Board of Parole Commissioners. The Parole Board relied on the same evidence that was presented to the disciplinary committee and revoked one hundred days of Pella’s statutory good time credit.

This matter is now before the Court on a trial de novo as to the merits of Pella’s due process claims. Pursuant to an order of this Court and based on stipulations from both parties, this case is being tried through sworn deposition testimony and trial briefs, and without live witness testimony or oral arguments. See Stipulation filed April 25, 1988. Both parties have agreed to employ the same expert to testify regarding the reliability and accuracy of the EMIT test, Dr. Roger Ritzlin, the director of toxicology at Sierra Nevada Laboratories. See Deposition of Dr. Ritzlin at 4:11-23 (July 13, 1988) (hereinafter “Ritzlin Depo”); Minute Orders of July 29 and July 31, 1987. We have previously ruled that the competence of the technician who performed the EMIT tests is not a proper subject for judicial review. Pella, 638 F.Supp. at 96-97. Hence, the only issues at trial are whether the defendants violated Pella’s due process rights by relying on the EMIT test or by denying him access to alternative urinalysis tests. 3

FINDINGS OF FACT

This Court has reviewed the uncontra-verted testimony of Dr. Ritzlin and finds it to be credible. According to Dr. Ritzlin, the EMIT test consists of mixing a urine sample with an antibody solution. If the *246 THC compound found in marijuana is present in the urine sample, it will increase the reaction in the system and, thereby, generate a positive test result. Ritzlin Depo at 9:6-8. Other compounds, however, including certain over-the-counter medications, can also react with the antibody solution and produce a positive test result. Id. at 9:17-19. Such positive test results, which are not caused by the presence of THC, and which can occur for a variety of reasons, are called “false positives.” Id. at 8:4-10.

Due to the possibility of a false positive result, the EMIT test is not 100% accurate. Even when an initial positive result is confirmed through a second EMIT test, such confirmation does not guarantee that the tested individual has been using marijuana or hashish. A second positive result simply confirms that the proper technical procedures were followed in performing the tests.' The same non-THC compound or other mystery factor that caused a false positive result in an initial EMIT test could also produce a false positive in the second EMIT test. Id. at 11:6-18.

Nevertheless, Dr. Ritzlin testified that the EMIT test generally yields accurate results. Assuming the test is performed correctly, the accuracy rate of EMIT tests is “considerably over 90%.” Id. at 15:5 — 11; 19:17-24. Indeed, if the test is done by qualified laboratory technicians and the results are confirmed by a second EMIT test, Dr. Ritzlin estimated that the incidence of false positive results could be as low as 1-2%. Id. at 15:5-11. Furthermore, Dr. Ritzlin stated that the EMIT test is relatively inexpensive, costing between $10 to $15 per test. Id. at 10:18-21.

In contrast, Dr. Ritzlin testified that the most accurate method of urinalysis costs approximately $45 per test. Id. at 10:11-24. This more expensive method is known as the Gas Liquid Chromatograph-Mass Spectrometer Test (“GLC-MS” test). It is, for all practical purposes, 100% accurate in determining precisely which drugs have been used by the tested individual. Id. at 12-13:24-1. Consequently, Dr. Ritzlin suggested that when accuracy is a paramount concern, the GLC-MS test should be used in conjunction with the EMIT test. Id; see also id. at 16:7-22; 24:2-12. Under such a program, the EMIT test would be used to screen urine samples at an initial low cost and then, if a positive result occurs, the GLC-MS test would be used to ensure that the result was not a false positive.

CONCLUSIONS OF LAW

A. Prison’s Use of the EMIT Test

Pella’s first argument is that on the basis of the evidence presented at his disciplinary hearing, the disciplinary committee could not find him guilty of ingesting marijuana.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Lucero
85 P.3d 1059 (Court of Appeals of Arizona, 2004)
Commonwealth v. Martin
696 N.E.2d 904 (Massachusetts Supreme Judicial Court, 1998)
Dailey v. Nebraska Department of Correctional Services
578 N.W.2d 869 (Nebraska Court of Appeals, 1998)
James A. Whitten, Jr. v. Jeffrey J. Clark, Warden
78 F.3d 587 (Seventh Circuit, 1996)
Rick Koenig v. Daniel Vannelli Douglas Trudeau
971 F.2d 422 (Ninth Circuit, 1992)
Rucker v. Johnson
724 F. Supp. 568 (N.D. Illinois, 1989)
Pella v. Adams
723 F. Supp. 1394 (D. Nevada, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
702 F. Supp. 244, 1988 U.S. Dist. LEXIS 15110, 1988 WL 138217, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pella-v-adams-nvd-1988.